COVID-19 vaccines are no longer blocking infections like they used to. Nasal vaccines could help patch up the holes where the new variants like BA.5 are getting in. Andy talks to physician and scientist Eric Topol about the promising trials underway, when we could see a nasal vaccine hit the market, and why it could transform our pandemic response by providing mucosal immunity.

Keep up with Andy on Twitter @ASlavitt.

Follow Eric Topol on Twitter @EricTopol.

Joining Lemonada Premium  is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium. 

Support the show by checking out our sponsors!

• Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/ 

Check out these resources from today’s episode: 

• Read Eric and Akiko Iwasaki’s piece about how nasal vaccines could achieve mucosal immunity against Omicron: https://www.science.org/doi/10.1126/sciimmunol.add9947
• Find vaccines, masks, testing, treatments, and other resources in your community: https://www.covid.gov/
• Order Andy’s book, “Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response”: https://us.macmillan.com/books/9781250770165 

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia. 

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.